Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson’s Disease

Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson’s Disease
J Parkinsons Dis. 2021 Apr 30. doi: 10.3233/JPD-212604. Online ahead of print.ABSTRACTBACKGROUND: Multiple system atrophy (MSA) and Parkinson's disease (PD) have overlapping symptoms, making diagnosis challenging. Short-chain fatty acids (SCFAs) are produced exclusively by gut microbiota and were reduced in feces of MSA patients. However, plasma SCFA concentrations in MSA patients have not been investigated.OBJECTIVE: We aimed to investigate the ... read more
Source: PubMedPublished on 2021-05-03By Xiaoqin He